CLINICAL_TRIALS
ClinicalTrials.gov record update
ImmuNomodulatory EffectS of PCSK9 Inhibition: A TaRgeted Molecular Imaging AppRoach
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05720156
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:15.520404+00:00
- Published At
- 2025-09-26T00:00:00+00:00
- Record Updated At
- 2025-09-26
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Atherosclerotic Cardiovascular Disease", "Cardiovascular Diseases", "Atherosclerosis", "Arterial Inflammation", "Vascular Diseases", "Vascular Disease, Peripheral", "Vascular Calcification", "High Cholesterol/Hyperlipidemia", "Heart Diseases", "Heart Attack", "Stroke", "Cerebrovascular Accident", "Carotid Artery Diseases", "Carotid Atherosclerosis", "Transient Ischemic Attack"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-09-26"- protocolSection.identificationModule.nctId
"NCT05720156"- protocolSection.identificationModule.officialTitle
"ImmuNomodulatory EffectS of PCSK9 Inhibition: A TaRgeted Molecular Imaging AppRoach"- protocolSection.statusModule.overallStatus
"WITHDRAWN"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.